Joanne Lemieux, a professor of biochemistry at the University of Alberta and his team who participated in a study have found that some drugs used to cure a form of intestinal coronavirus in cats could work against Covid 19 too. “This drug is very likely to work in humans, so we’re encouraged that it will be an effective antiviral treatment for COVID-19 patients,” he said. Like humans, cats can also catch an equally fatal disease caused by a strain of the coronavirus. It is known as feline infectious peritonitis, a condition in which the virus invades the cells of a cat’s intestinal walls.
Experiments have been done with two drugs: GC376 and GS-441524. They work by disabling Mpro, a protease found in different strains of coronavirus including the SARS-CoV-2. After, the novel coronavirus is unable to replicate itself. GC376 can be classified as a protease inhibitor. The research team is about to start phase I (human) clinical trials. The previous work was promision. “In just two months, our results have shown that the drug is effective at inhibiting viral replication in cells with SARS-CoV-2,” professor Joanne Lemieux said in a statement. The coronavirus pandemic is now affecting 188 countries and territories. The numbers of cases worldwide has topped 25.12 million.